AFYA logo

AFYA Afya Limited

NASDAQ Global Select · Education & Training Services · Consumer Defensive

$13.84
+0.43 (+3.21%)

Afya Limited, operating through its subsidiaries, is a prominent medical education provider in Brazil. The company delivers a comprehensive array of educational products and services primarily focused on the medical field, encompassing medical schools, preparatory courses for medical residency, advanced graduate studies, and various other programs tailored for medical professionals at all career s…

Market Cap: $1.25Binstitucional.afya.com.br

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 13Aug 13

Quote

Day Range
$13.33 – $13.90
52-Week Range
$13.00 – $16.50
Volume
$167.6K
Market Cap
$1.25B
50-Day Avg
$14.24
200-Day Avg
$14.48
Prev Close
$13.41
Open
$13.40

Valuation & Ratios

P/E Ratio
10.34
EPS
$8.15
P/B Ratio
1.57
P/S Ratio
2.11
Debt/Equity
0.64
Current Ratio
2.20
Dividend Yield
+1.5%
Gross Margin
+64.5%

Returns & Efficiency

Return on Equity
+15.2%
Return on Assets
+7.9%
FCF Yield
+13.6%
EV/EBITDA
7.20

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$3.62B$737.68M$8.16
2024$3.30B$631.51M$7.01
2023$2.88B$386.32M$4.27
2022$2.33B$373.57M$4.15
2021$1.72B$223.33M$2.39

Social Signal Score

52
5d
52
4 mentions
30d
51
4 mentions
60d
51
4 mentions
90d
51
4 mentions
news: 4

Earnings

Thu, Nov 12(in 3 months)

Consensus estimate $0.41 per share

7of 7 quarters beat consensus

Typical surprise +7.9% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 13$0.45 vs $0.39beat
  • Thu, May 7$0.56 vs $0.53beat
  • Thu, Mar 12$0.41 vs $0.38beat
  • Wed, Nov 12$0.38 vs $0.32beat
  • Wed, Aug 13$0.40 vs $0.40beat
  • Thu, May 8$0.55 vs $0.46beat

Estimates and results for AFYA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from AFYA's reported EPS growth of 35.9% a year over 4 years. Historical EPS growth of 36% reflects a recovery from a low base and won't persist. Capped at 30% as a starting point.

EPS in 5 years
$30.27
Implied price
$302.73
Return from $13.84
85.3% a year

To earn 15.0% a year on these assumptions you'd need to buy at $150.51 — today's price is already 90.8% below that.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E68101214
20.0%54.5%63.6%71.1%77.4%83.0%
25.0%60.9%70.4%78.2%84.8%90.6%
30.0%67.3%77.3%85.3%92.2%98.2%
35.0%73.8%84.1%92.5%99.6%105.9%
40.0%80.2%90.9%99.6%107.0%113.5%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (4)

  • Newszacks.com·1d ago·Negative

    Afya (AFYA) Q2 Earnings and Revenues Lag Estimates Afya (AFYA) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.4 per share a year ago.

    View source ↗
  • Newsmarketbeat.com·1d ago·Neutral

    Afya Q2 Earnings Call Highlights Afya NASDAQ: AFYA reported first-half 2026 revenue of BRL 1.985 billion, up 7% from a year earlier, while adjusted EBITDA rose 3% to BRL 918 million. Net income increased 7% to BRL 463 million, and basic earnings per share rose 9% to BRL 5.10.

    View source ↗
  • Newsseekingalpha.com·1d ago·Positive

    Afya Limited (AFYA) Q2 2026 Earnings Call Transcript Afya Limited (AFYA) Q2 2026 Earnings Call Transcript

    View source ↗
  • Newsbusinesswire.com·1d ago·Neutral

    Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with Inter…

    View source ↗